Skip to main content

Davol Dulex Product Liability Claims Allowed To Proceed

Davol Dulex Product Liability Claims Allowed To Proceed

Davol Dulex Product Liability Claims Allowed To Proceed

Introduction

In an order issued on September 12, Judge Pamela Reeves of the U.S District Court for the Eastern District of Tennessee allowed product liability claims by Plaintiff Martha Karen Jones against Davol, Bard in Davol Dulex hernia mesh case to proceed.

However, the breach of warranty claim has been time-barred since it was not filed within the four-year statute of limitations period. The plaintiff underwent hernia surgery in 2008. Later, in 2012, the mesh got infected and had to be removed requiring additional surgeries until May 2017. Jones then filed a complaint against C.R. Bard and Davol for false marketing the defectively designed hernia mesh.

Lawsuits linked to hernia mesh complications are expected to go to trial in 2019. The multidistrict litigation (MDL No.2782; In Re: Ethicon Physiomesh Flexible composite Hernia Mesh Products Liability Litigation) was formed in June 2017 before U.S. District Judge Richard Story in the Northern District of Georgia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.